# Title

 Animals and Animal Products. PART 121â€”POSSESSION, USE, AND TRANSFER OF SELECT AGENTS AND TOXINS


# ID

 CFR-2018-title9-vol1.Pt. 121


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['at least', 'within', 'lesser', 'prior to', 'after', 'maximum of', 'greater', 'minimum of', 'before', 'exceed']                                                                                                                                                                                                                                                                                                                                                                                             |
| Duration    | ['7.0 day', '3.0 year', '180.0 day', '30.0 day', '15.0 minute', '90.0 day', '5.0 minute', '2.0 day', '48.0 hour', '12.0 month', '14.0 day', '24.0 hour']                                                                                                                                                                                                                                                                                                                                                     |
| Condition   | ['when', 'unless', 'subject to', 'as soon as', 'until', 'provided that', 'if', 'where']                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Entities    | ['United States', 'Newcastle', 'Synthetic', 'Training', 'Information', 'Columbia', 'Puerto Rico', 'Venezuelan', 'Fungicide', 'Swine', 'Diagnosis', 'Overlap', 'Bacillus', 'Administrator', 'Burkholderia', 'Toxin', 'Denial', 'Federal', 'Verification', 'Principal', 'Entity', 'Select', 'Purpose', 'Responsible', 'Sheep', 'Import', 'Biosafety', 'Mycoplasma', 'Permit', 'Biological', 'Agriculture', 'USDA', 'Security', 'Avian', 'Microbiological', 'African', 'Nipah', 'Brucella', 'Health', 'Animal'] |
| Date        | ['2018-01-01']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                   |
|:--------------|:--------------------------------------------------------------------------------------------------------------------------|
| within        | State into or through any other State, or within the District of Columbia, Guam, the Virgin Islands                       |
| lesser        | procedure, then an inactivation procedure validated on a lesser resistant strain must also be validated on the            |
| within        | destruction by complying with State and Federal regulations within 7 calendar days of the conclusion of patient           |
| within        | or entity can identify that the agent is within  the exclusion category.                                                  |
| within        | VS select agents and toxins must be reported within 24 hours by telephone, facsimile, or e-mail: African                  |
| within        | be followed by submission of APHIS/CDC Form 4 within 7 calendar days after seizure of the select                          |
| after         | of APHIS/CDC Form 4 within 7 calendar days after  seizure of the select agent or toxin.                                   |
| within        | or toxins, APHIS/CDC Form 4 must be submitted within 7 calendar days after seizure of the agent                           |
| after         | 4 must be submitted within 7 calendar days after  seizure of the agent or toxin.                                          |
| lesser        | procedure, then an inactivation procedure validated on a lesser resistant strain must also be validated on the            |
| within        | destruction by complying with State and Federal regulations within 7 calendar days of the conclusion of patient           |
| within        | or entity can identify that the agent is within  the exclusion category.                                                  |
| within        | overlap select agents and toxins must be reported within 24 hours by telephone, facsimile, or e-mail: Bacillus            |
| within        | be followed by submission of APHIS/CDC Form 4 within 7 calendar days after seizure of the overlap                         |
| after         | of APHIS/CDC Form 4 within 7 calendar days after  seizure of the overlap select agent or toxin.                           |
| within        | or toxins, APHIS/CDC Form 4 must be submitted within 7 calendar days after seizure of the agent                           |
| after         | 4 must be submitted within 7 calendar days after  seizure of the agent or toxin.                                          |
| within        | that: (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select       |
| after         | otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the             |
| within        | that: (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select       |
| after         | otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the             |
| within        | of APHIS/CDC Form 4 to APHIS or CDC within  7 calendar days after identification.                                         |
| after         | to APHIS or CDC within 7 calendar days after  identification.                                                             |
| within        | that: (1) Unless directed otherwise by the Administrator, within 90 calendar days of receipt, the agent or                |
| within        | or toxin, APHIS/CDC Form 4 must be submitted within 90 days of receipt of the agent or                                    |
| maximum of    | If granted, such exemptions are valid for a  maximum of 3 years; thereafter, an individual or entity must                 |
| after         | valid for a maximum of 3 years; there after , an individual or entity must request a                                      |
| within        | that: (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select       |
| after         | otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the             |
| within        | that: (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select       |
| after         | otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the             |
| within        | of APHIS/CDC Form 4 to APHIS or CDC within  7 calendar days after identification.                                         |
| after         | to APHIS or CDC within 7 calendar days after  identification.                                                             |
| within        | otherwise by the Administrator or the HHS Secretary, within 90 days of receipt, the agent or toxin                        |
| within        | or toxin, APHIS/CDC Form 4 must be submitted within 90 calendar days of receipt of the agent                              |
| after         | necessary to protect animal health or animal products. after                                                              |
| within        | Administrator will make a determination regarding an exemption within 14 calendar days after receipt of the application   |
| after         | determination regarding an exemption within 14 calendar days after receipt of the application and notification that the   |
| prior to      | submitting the relevant page(s) of the registration application. prior to                                                 |
| prior to      | submitting the relevant page(s) of the registration application.&#8201;9 prior to                                         |
| maximum of    | certificate of registration will be valid for a maximum of  3 years.                                                      |
| within        | individual who owns or controls the entity is within any of the categories described in 18 U.S.C.                         |
| after         | or receives any report of any inactivation failure after the movement of material to another location, the                |
| after         | The review must be conducted annually or  after any change in principal investigator, change in the                       |
| within        | be reported by submission of APHIS/CDC Form 4 within  7 calendar days after identification.                               |
| after         | of APHIS/CDC Form 4 within 7 calendar days after  identification.                                                         |
| within        | or toxin, APHIS/CDC Form 4 must be submitted within  7 calendar days after identification.                                |
| after         | 4 must be submitted within 7 calendar days after  identification.                                                         |
| within        | or toxin, APHIS/CDC Form 4 must be submitted within 90 calendar days of receipt of the agent                              |
| within        | limited, or revoked if: (1) The individual is within any of the categories described in 18 U.S.C.                         |
| within        | be denied or revoked if the individual is within any of the categories described in 18 U.S.C.                             |
| maximum of    | (j) Access approval is valid for a  maximum of  3 years.                                                                  |
| greater       | or implement measures to achieve an equivalent or greater level of security: (1) Allow access only to                     |
| before        | system, lock boxes); (4) Inspect all suspicious packages before they are brought into or removed from an                  |
| minimum of    | on the entity's site-specific risk assessment; (iv) A minimum of three security barriers where each security barrier adds |
| exceed        | for security forces or local police will not exceed 15 minutes where the response time is measured                        |
| minimum of    | have the following additional security requirements: (i) A minimum of four barriers, one of which must be a               |
| exceed        | Response time must not  exceed 5 minutes from the time of an intrusion                                                    |
| at least      | Drills or exercises must be conducted  at least annually to test and evaluate the effectiveness of                        |
| after         | plan must be reviewed and revised, as necessary, after  any drill or exercise and                                         |
| after         | plan must be reviewed and revised, as necessary, after  any drill or exercise and                                         |
| at least      | Drills or exercises must be conducted  at least annually to test and evaluate the effectiveness of                        |
| after         | plan must be reviewed and revised, as necessary, after  any drill or exercise and                                         |
| after         | plan must be reviewed and revised, as necessary, after  any drill or exercise and                                         |
| at least      | Drills or exercises must be conducted  at least annually to test and evaluate the effectiveness of                        |
| after         | plan must be reviewed and revised, as necessary, after  any drill or exercise and                                         |
| after         | plan must be reviewed and revised, as necessary, after  any drill or exercise and                                         |
| prior to      | The training must be accomplished  prior to the individual's entry into an area where a                                   |
| within        | a select agent is handled or stored, or within 12 months of the date the individual was                                   |
| before        | and toxins by the Administrator or HHS Secretary before that individual enters areas under escort where select            |
| prior to      | The training must be accomplished  prior to the individual's entry into where select agents or                            |
| prior to      | and must be authorized by APHIS or CDC prior to  the transfer.&#8201;14                                                   |
| at least      | prior authorization from APHIS or CDC provided that, at least 7 calendar days prior to the transfer, the                  |
| prior to      | CDC provided that, at least 7 calendar days prior to the transfer, the sender reports to APHIS or                         |
| after         | in compliance with all applicable laws concerning packaging. after                                                        |
| within        | recipient must submit a completed APHIS/CDC Form 2 within 2 business days of receipt of a select                          |
| within        | select agent or toxin has not been received within 48 hours after the expected delivery time or                           |
| after         | toxin has not been received within 48 hours after the expected delivery time or if the package                            |
| after         | shall be valid only for 30 calendar days after issuance, except that such an authorization becomes immediately            |
| after         | (l) Transfer the amounts only  after the transferor uses due diligence and documents that                                 |
| prior to      | and records to ensure compliance with this part. prior to                                                                 |
| within        | A completed APHIS/CDC Form 3 must be submitted within  7 calendar days.                                                   |
| within        | A completed APHIS/CDC Form 3 must be submitted within  7 calendar days.                                                   |
| within        | the appeal, and be submitted to the Administrator within  30 calendar days of the decision.                               |
| within        | the appeal, and be submitted to the Administrator within  180 calendar days of the decision.                              |


## Duration

| Duration    | Context                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 7.0 day     | (8) Waste generated during the delivery of patient care by health care professionals from a patient diagnosed with an illness or condition associated with a select agent, where that waste is decontaminated or transferred for destruction by complying with State and Federal regulations within 7 calendar days of the conclusion of patient care.                                                                                 |
| 24.0 hour   | (i) The seizure of any of the following VS select agents and toxins must be reported within 24 hours by telephone, facsimile, or e-mail: African horse sickness virus, African swine fever virus, avian influenza virus (highly pathogenic), bovine spongiform encephalopathy agent, classical swine fever virus, foot-and-mouth disease virus, virulent Newcastle disease virus, rinderpest virus, and swine vesicular disease virus. |
| 7.0 day     | This report must be followed by submission of APHIS/CDC Form 4 within 7 calendar days after seizure of the select agent or toxin.                                                                                                                                                                                                                                                                                                      |
| 7.0 day     | (ii) For all other VS select agents or toxins, APHIS/CDC Form 4 must be submitted within 7 calendar days after seizure of the agent or toxin.                                                                                                                                                                                                                                                                                          |
| 3.0 year    | (iii) A copy of APHIS/CDC Form 4 must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 7.0 day     | (8) Waste generated during the delivery of patient care by health care professionals from a patient diagnosed with an illness or condition associated with a select agent, where that waste is decontaminated or transferred for destruction by complying with State and Federal regulations within 7 calendar days of the conclusion of patient care.                                                                                 |
| 24.0 hour   | (i) The seizure of any of the following overlap select agents and toxins must be reported within 24 hours by telephone, facsimile, or e-mail: Bacillus anthracis, Burkholderia mallei, or Burkholderia pseudomallei.                                                                                                                                                                                                                   |
| 7.0 day     | This report must be followed by submission of APHIS/CDC Form 4 within 7 calendar days after seizure of the overlap select agent or toxin.                                                                                                                                                                                                                                                                                              |
| 7.0 day     | (ii) For all other overlap select agents or toxins, APHIS/CDC Form 4 must be submitted within 7 calendar days after seizure of the agent or toxin.                                                                                                                                                                                                                                                                                     |
| 3.0 year    | (iii) A copy of APHIS/CDC Form 4 must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 7.0 day     | (a) Diagnostic laboratories and other entities that possess, use, or transfer a VS select agent or toxin that is contained in a specimen presented for diagnosis or verification will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:                                                                                                                                   |
|             |             (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the select agent or toxin is transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process;                                                                                                                                  |
|             |             (2) The agent or toxin is secured against theft, loss, or release during the period between identification of the agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported;                                                                                                                                                                   |
|             |             (3) Unless otherwise directed by the Administrator, the clinical or diagnostic specimens collected from a patient infected with a select agent are transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process within 7 calendar days after delivery of patient care by heath care professionals has concluded; and                                      |
|             |             (4) The identification of the agent or toxin is reported to APHIS or CDC, the specimen provider, and to other appropriate authorities when required by Federal, State, or local law by telephone, facsimile, or email.                                                                                                                                                                                                     |
| 7.0 day     | (a) Diagnostic laboratories and other entities that possess, use, or transfer a VS select agent or toxin that is contained in a specimen presented for diagnosis or verification will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:                                                                                                                                   |
|             |             (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the select agent or toxin is transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process;                                                                                                                                  |
|             |             (2) The agent or toxin is secured against theft, loss, or release during the period between identification of the agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported;                                                                                                                                                                   |
|             |             (3) Unless otherwise directed by the Administrator, the clinical or diagnostic specimens collected from a patient infected with a select agent are transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process within 7 calendar days after delivery of patient care by heath care professionals has concluded; and                                      |
|             |             (4) The identification of the agent or toxin is reported to APHIS or CDC, the specimen provider, and to other appropriate authorities when required by Federal, State, or local law by telephone, facsimile, or email.                                                                                                                                                                                                     |
| 7.0 day     | This report must be followed by submission of APHIS/CDC Form 4 to APHIS or CDC within 7 calendar days after identification.                                                                                                                                                                                                                                                                                                            |
| 90.0 day    | (b) Diagnostic laboratories and other entities that possess, use, or transfer a VS select agent or toxin that is contained in a specimen presented for proficiency testing will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:                                                                                                                                         |
|             |             (1) Unless directed otherwise by the Administrator, within 90 calendar days of receipt, the agent or toxin is transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process;                                                                                                                                                                               |
|             |             (2) The agent or toxin is secured against theft, loss, or release during the period between identification of the agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported; and                                                                                                                                                               |
|             |             (3) The identification of the agent or toxin, and its derivative, is reported to APHIS or CDC.                                                                                                                                                                                                                                                                                                                             |
| 90.0 day    | To report the identification of a select agent or toxin, APHIS/CDC Form 4 must be submitted within 90 days of receipt of the agent or toxin.                                                                                                                                                                                                                                                                                           |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 3.0 year    | If granted, such exemptions are valid for a maximum of 3 years; thereafter, an individual or entity must request a new exemption.                                                                                                                                                                                                                                                                                                      |
| 7.0 day     | (a) Clinical or diagnostic laboratories and other entities that possess, use, or transfer an overlap select agent or toxin that is contained in a specimen presented for diagnosis or verification will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:                                                                                                                 |
|             |             (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the select agent or toxin is transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process;                                                                                                                                  |
|             |             (2) The agent or toxin is secured against theft, loss, or release during the period between identification of the agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported;                                                                                                                                                                   |
|             |             (3) Unless otherwise directed by the Administrator or HHS Secretary, the clinical or diagnostic specimens collected from a patient infected with a select agent are transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process within 7 calendar days after delivery of patient care by heath care professionals has concluded; and                     |
|             |             (4) The identification of the agent or toxin is reported to APHIS or CDC, the specimen provider, and to other appropriate authorities when required by Federal, State, or local law by telephone, facsimile, or email.                                                                                                                                                                                                     |
| 7.0 day     | (a) Clinical or diagnostic laboratories and other entities that possess, use, or transfer an overlap select agent or toxin that is contained in a specimen presented for diagnosis or verification will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:                                                                                                                 |
|             |             (1) Unless directed otherwise by the Administrator, within 7 calendar days after identification of the select agent or toxin, the select agent or toxin is transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process;                                                                                                                                  |
|             |             (2) The agent or toxin is secured against theft, loss, or release during the period between identification of the agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported;                                                                                                                                                                   |
|             |             (3) Unless otherwise directed by the Administrator or HHS Secretary, the clinical or diagnostic specimens collected from a patient infected with a select agent are transferred in accordance with &#167;&#8201;121.16 or destroyed on-site by a recognized sterilization or inactivation process within 7 calendar days after delivery of patient care by heath care professionals has concluded; and                     |
|             |             (4) The identification of the agent or toxin is reported to APHIS or CDC, the specimen provider, and to other appropriate authorities when required by Federal, State, or local law by telephone, facsimile, or email.                                                                                                                                                                                                     |
| 7.0 day     | This report must be followed by submission of APHIS/CDC Form 4 to APHIS or CDC within 7 calendar days after identification.                                                                                                                                                                                                                                                                                                            |
| 90.0 day    | (b) Clinical or diagnostic laboratories and other entities that possess, use, or transfer an overlap select agent or toxin that is contained in a specimen presented for proficiency testing will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:                                                                                                                       |
|             |             (1) Unless directed otherwise by the Administrator or the HHS Secretary, within 90 days of receipt, the agent or toxin is transferred in accordance with &#167;&#8201;121.16 or 42 CFR 73.16 or destroyed on-site by a recognized sterilization or inactivation process;                                                                                                                                                   |
|             |             (2) The agent or toxin is secured against theft, loss, or release during the period between identification of the agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported; and                                                                                                                                                               |
|             |             (3) The identification of the agent or toxin, and its derivative, is reported to APHIS or CDC.                                                                                                                                                                                                                                                                                                                             |
| 90.0 day    | To report the identification of an overlap select agent or toxin, APHIS/CDC Form 4 must be submitted within 90 calendar days of receipt of the agent or toxin.                                                                                                                                                                                                                                                                         |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | (2) The Administrator will make a determination regarding an exemption within 14 calendar days after receipt of the application and notification that the investigation has been authorized under a Federal law.                                                                                                                                                                                                                       |
| 30.0 day    | (e) If it is necessary to respond to a domestic or foreign agricultural emergency involving an overlap select agent or toxin, the Administrator may exempt an individual or entity from the requirements, in whole or in part, of this part for up to 30 calendar days.                                                                                                                                                                |
| 30.0 day    | The Administrator may extend the exemption once for an additional 30 days.                                                                                                                                                                                                                                                                                                                                                             |
| 30.0 day    | (f) Upon request of the Secretary of Health and Human Services, the Administrator may exempt an individual or entity from the requirements, in whole or in part, of this part for up to 30 calendar days if the Secretary of Health and Human Services has granted an exemption for a public health emergency involving an overlap select agent or toxin.                                                                              |
| 30.0 day    | The Administrator may extend the exemption once for an additional 30 days.                                                                                                                                                                                                                                                                                                                                                             |
| 3.0 year    | (l) A certificate of registration will be valid for a maximum of 3 years.                                                                                                                                                                                                                                                                                                                                                              |
| 7.0 day     | The final disposition of the agent or toxin must be reported by submission of APHIS/CDC Form 4 within 7 calendar days after identification.                                                                                                                                                                                                                                                                                            |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 7.0 day     | (2) To report the identification and final disposition of any other select agent or toxin, APHIS/CDC Form 4 must be submitted within 7 calendar days after identification.                                                                                                                                                                                                                                                             |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 90.0 day    | To report the identification and final disposition of a select agent or toxin, APHIS/CDC Form 4 must be submitted within 90 calendar days of receipt of the agent or toxin.                                                                                                                                                                                                                                                            |
| 3.0 year    | A copy of the completed form must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                           |
| 3.0 year    | (j) Access approval is valid for a maximum of 3 years.                                                                                                                                                                                                                                                                                                                                                                                 |
| 15.0 minute | (A) Determine that the response time for security forces or local police will not exceed 15 minutes where the response time is measured from the time of an intrusion alarm, or report of a security incident, to the arrival of the responders at the first security barrier or;                                                                                                                                                      |
|             |             (B) Provide security barriers that are sufficient to delay unauthorized access until the response force arrives in order to safeguard the select agents and toxins from theft, intentional release, or unauthorized access.                                                                                                                                                                                                |
| 24.0 hour   | (5) Entities that possess foot-and-mouth disease virus and rinderpest virus must have the following additional security requirements:                                                                                                                                                                                                                                                                                                  |
|             |             (i) A minimum of four barriers, one of which must be a perimeter security fence or equivalent which is monitored 24 hours a day, 7 days a week (24/7) to detect the presence of unauthorized persons, vehicles, materials, or unauthorized activities;                                                                                                                                                                     |
|             |             (ii) Onsite 24/7 armed security response force with roving patrol.                                                                                                                                                                                                                                                                                                                                                         |
| 7.0 day     | (5) Entities that possess foot-and-mouth disease virus and rinderpest virus must have the following additional security requirements:                                                                                                                                                                                                                                                                                                  |
|             |             (i) A minimum of four barriers, one of which must be a perimeter security fence or equivalent which is monitored 24 hours a day, 7 days a week (24/7) to detect the presence of unauthorized persons, vehicles, materials, or unauthorized activities;                                                                                                                                                                     |
|             |             (ii) Onsite 24/7 armed security response force with roving patrol.                                                                                                                                                                                                                                                                                                                                                         |
| 5.0 minute  | Response time must not exceed 5 minutes from the time of an intrusion alarm or report of a security incident;                                                                                                                                                                                                                                                                                                                          |
|             |             (iii) CCTV surveillance with 24/7 monitoring and recording; and                                                                                                                                                                                                                                                                                                                                                            |
|             |             (iv) Transport vehicle with GPS tracking designed to serve as a containment vehicle.                                                                                                                                                                                                                                                                                                                                       |
| 12.0 month  | The training must be accomplished prior to the individual's entry into an area where a select agent is handled or stored, or within 12 months of the date the individual was approved by the Administrator or the HHS Secretary for access, whichever is earlier.                                                                                                                                                                      |
| 7.0 day     | (c) A select agent or toxin that is contained in a specimen for proficiency testing may be transferred without prior authorization from APHIS or CDC provided that, at least 7 calendar days prior to the transfer, the sender reports to APHIS or CDC the select agent or toxin to be transferred and the name and address of the recipient.                                                                                          |
| 2.0 day     | (i) The recipient must submit a completed APHIS/CDC Form 2 within 2 business days of receipt of a select agent or toxin.                                                                                                                                                                                                                                                                                                               |
| 48.0 hour   | (j) The recipient must immediately notify APHIS or CDC if the select agent or toxin has not been received within 48 hours after the expected delivery time or if the package containing the select agent or toxin has been damaged to the extent that a release of the select agent or toxin may have occurred.                                                                                                                        |
| 30.0 day    | (k) An authorization for a transfer shall be valid only for 30 calendar days after issuance, except that such an authorization becomes immediately null and void if any facts supporting the authorization change (e.g., change in the certificate of registration for the sender or recipient, change in the application for transfer).                                                                                               |
| 3.0 year    | All records created under this part must be maintained for 3 years.                                                                                                                                                                                                                                                                                                                                                                    |
| 7.0 day     | (2) A completed APHIS/CDC Form 3 must be submitted within 7 calendar days.                                                                                                                                                                                                                                                                                                                                                             |
| 7.0 day     | (2) A completed APHIS/CDC Form 3 must be submitted within 7 calendar days.                                                                                                                                                                                                                                                                                                                                                             |
| 30.0 day    | The appeal must be in writing, state the factual basis for the appeal, and be submitted to the Administrator within 30 calendar days of the decision.                                                                                                                                                                                                                                                                                  |
| 180.0 day   | The appeal must be in writing, state the factual basis for the appeal, and be submitted to the Administrator within 180 calendar days of the decision.                                                                                                                                                                                                                                                                                 |


## Condition

| Condition     | Context                                                                                                                                        |
|:--------------|:-----------------------------------------------------------------------------------------------------------------------------------------------|
| provided that | or characteristics of a select agent or toxin, provided that such analysis is directly related to protecting the                               |
| unless        | and Human Services or his or her designee, unless  otherwise specified.                                                                        |
| subject to    | Overlap select agents and toxins are  subject to  regulation by both APHIS and CDC.                                                            |
| subject to    | Tier 1 select agents and toxins and are subject to  additional requirements as listed in this part.                                            |
| if            | toxin listed in paragraph (b) of this section if the nucleic acids: (i) Can be expressed in                                                    |
| provided that | toxin that is in its naturally occurring environment, provided that the agent or toxin has not been intentionally                              |
| when          | been subjected to decontamination or a destruction procedure when  intended for waste disposal.                                                |
| if            | be used to validate an inactivation procedure; however, if there are known strain-to-strain variations in the resistance                       |
| if            | viable select agent cells, spores, or virus particles if the material is subjected to a viability testing                                      |
| if            | viable select agent cells, spores, or virus particles if the material is determined by the Administrator to                                    |
| where         | illness or condition associated with a select agent, where that waste is decontaminated or transferred for destruction                         |
| provided that | mycoides small colony (Mmm SC) (contagious bovine pleuropneumonia), provided that the individual or entity can identify that the               |
| if            | (2) If an excluded attenuated strain or mod if ied toxin is subjected to any manipulation that                                                 |
| subject to    | the resulting select agent or toxin will be subject to  the requirements of this part.                                                         |
| as soon as    | toxin by a recognized sterilization or inactivation process. as soon as                                                                        |
| subject to    | Tier 1 select agents and toxins and are subject to  additional requirements as listed in this part.                                            |
| if            | toxin listed in paragraph (b) of this section if the nucleic acids: (i) Can be expressed in                                                    |
| provided that | toxin that is in its naturally occurring environment, provided that the agent or toxin has not been intentionally                              |
| when          | been subjected to decontamination or a destruction procedure when  intended for waste disposal.                                                |
| if            | be used to validate an inactivation procedure; however, if there are known strain-to-strain variations in the resistance                       |
| if            | viable select agent cells, spores, or virus particles if the material is subjected to a viability testing                                      |
| if            | viable select agent cells, spores, or virus particles if the material is determined by the Administrator or                                    |
| where         | illness or condition associated with a select agent, where that waste is decontaminated or transferred for destruction                         |
| provided that | encephalitis virus except for Subtypes IAB or IC, provided that the individual or entity can identify that the                                 |
| if            | (2) If an excluded attenuated strain or mod if ied toxin is subjected to any manipulation that                                                 |
| subject to    | the resulting select agent or toxin will be subject to  the requirements of this part.                                                         |
| as soon as    | toxin by a recognized sterilization or inactivation process. as soon as                                                                        |
| unless        | or local law by telephone, facsimile, or email. unless                                                                                         |
| unless        | or local law by telephone, facsimile, or email. unless                                                                                         |
| when          | the specimen provider, and to other appropriate authorities when required by Federal, State, or local law by                                   |
| unless        | its derivative, is reported to APHIS or CDC. unless                                                                                            |
| unless        | been cleared, approved, licensed, or registered pursuant to: unless                                                                            |
| if            | be exempt from the requirements of this part if the products have been cleared, approved, licensed, or                                         |
| if            | or contains a VS select agent or toxin if such product is being used in an investigation                                                       |
| when          | The applicant must notify APHIS  when  an authorization for an investigation no longer exists.                                                 |
| when          | This exemption automatically terminates  when  such authorization is no longer in effect.                                                      |
| unless        | or local law by telephone, facsimile, or email. unless                                                                                         |
| unless        | or local law by telephone, facsimile, or email. unless                                                                                         |
| when          | the specimen provider, and to other appropriate authorities when required by Federal, State, or local law by                                   |
| unless        | its derivative, is reported to APHIS or CDC. unless                                                                                            |
| unless        | been cleared, approved, licensed, or registered pursuant to: unless                                                                            |
| if            | order determines that additional regulation of a spec if ic product is necessary to protect animal health                                      |
| if            | or contains an overlap select agent or toxin if such product is being used in an investigation                                                 |
| when          | (3) The applicant must notify APHIS or CDC  when  an authorization for an investigation no longer exists.                                      |
| when          | This exemption automatically terminates  when  such authorization is no longer in effect.                                                      |
| if            | this part for up to 30 calendar days. if                                                                                                       |
| if            | this part for up to 30 calendar days if the Secretary of Health and Human Services has                                                         |
| unless        | a certificate of registration issued by the Administrator. unless                                                                              |
| unless        | any individual who owns or controls the entity. unless                                                                                         |
| if            | be deemed to own or control the entity if the individual is in a managerial or executive                                                       |
| if            | be deemed to own or control the entity if the individual: (A) Owns 50 percent or more                                                          |
| if            | considered to be an institution of higher education if it is an institution of higher education as                                             |
| where         | room, a building, or a group of buildings) where the responsible official will be able to perform                                              |
| if            | (2) The responsible official will be not if ied in writing                                                                                     |
| if            | (j) An entity must immediately not if y APHIS or CDC                                                                                           |
| if            | possess or use select agents or toxins only if it appoints as the responsible official another individual                                      |
| if            | (k) A cert if icate of registration will be terminated upon the                                                                                |
| until         | a certificate of registration will remain in effect until  a final agency decision has been rendered.                                          |
| where         | annual inspections are conducted for each registered space where select agents or toxins are stored or used                                    |
| if            | must be documented and training must be conducted if there are any changes to the validated inactivation                                       |
| when          | and control to ensure compliance with the regulations when  acting as the responsible official.                                                |
| unless        | may not access a select agent or toxin, unless the individual is approved by the Administrator or                                              |
| if            | to have access at any point in time if the individual has possession of a select agent                                                         |
| if            | A responsible official must immediately not if y the responsible official of the visited entity                                                |
| if            | individual's access approval will be denied or revoked if the individual is within any of the categories                                       |
| when          | responsible official must immediately notify APHIS or CDC when an individual's access to select agents or toxins                               |
| when          | submitted for initial registration, renewal of registration, or when  requested.                                                               |
| when          | roles and responsibilities, and that access is modified when  the user's roles and responsibilities change or                                  |
| when          | roles and responsibilities, and that access is modified when  the user's roles and responsibilities change or                                  |
| when          | not related to select agents or toxins only when continuously escorted by an approved individual if the                                        |
| if            | only when continuously escorted by an approved individual if the potential to access to select agents or                                       |
| where         | by requiring freezers, refrigerators, cabinets, and other containers where select agents or toxins are stored to be                            |
| where         | by requiring freezers, refrigerators, cabinets, and other containers where select agents or toxins are stored to be                            |
| where         | (8) Separate areas  where select agents and toxins are stored or used                                                                          |
| when          | affected select agents and toxins in long-term storage when any of the following occur: (1) Upon the                                           |
| subject to    | had an entity-conducted pre-access suitability assessment, and are subject to the entity's procedures for ongoing suitability assessment; (ii) |
| where         | assessment; (iv) A minimum of three security barriers where each security barrier adds to the delay in                                         |
| where         | assessment; (iv) A minimum of three security barriers where each security barrier adds to the delay in                                         |
| unless        | be protected by an intrusion detection system (IDS) unless physically occupied; (vi) Personnel monitoring the IDS must                         |
| where         | or local police will not exceed 15 minutes where the response time is measured from the time                                                   |
| until         | barriers that are sufficient to delay unauthorized access until the response force arrives in order to safeguard                               |
| when          | submitted for initial registration, renewal of registration, or when  requested.                                                               |
| unless        | or possess products resulting from, the following experiments unless approved by and conducted in accordance with the                          |
| if            | are not known to acquire the trait naturally, if such acquisition could compromise the control of disease                                      |
| if            | this section, or revoke or suspend a cert if icate of registration,                                                                            |
| when          | submitted for initial registration, renewal of registration, or when  requested.                                                               |
| where         | contact information for the building owner and/or manager, where applicable; (3) The name and contact information for                          |
| where         | contact information for the building owner and/or manager, where applicable; (3) The name and contact information for                          |
| where         | contact information for the building owner and/or manager, where applicable; (3) The name and contact information for                          |
| where         | prior to the individual's entry into an area where a select agent is handled or stored, or                                                     |
| where         | Secretary before that individual enters areas under escort where select agents or toxins are handled or stored                                 |
| where         | based on the risk associated with accessing areas where  select agents and toxins are used and/or stored.                                      |
| where         | be accomplished prior to the individual's entry into where select agents or toxins are handled or stored                                       |
| provided that | transferred without prior authorization from APHIS or CDC provided that , at least 7 calendar days prior to                                    |
| when          | (h) Transportation in commerce starts  when the select agent(s) or toxin(s) are packaged for                                                   |
| when          | (h) Transportation in commerce starts  when the select agent(s) or toxin(s) are packaged for                                                   |
| if            | (j) The recipient must immediately not if y APHIS or CDC                                                                                       |
| if            | (j) The recipient must immediately not if y APHIS or CDC                                                                                       |
| if            | such an authorization becomes immediately null and void if any facts supporting the authorization change (e.g., change                         |
| where         | individual or entity (e.g., containers, vials, tubes, etc. where                                                                               |
| when          | When moved from storage and by whom and when returned to storage and by whom; (v) The                                                          |
| when          | When moved from storage and by whom and when returned to storage and by whom; (v) The                                                          |
| when          | When moved from storage and by whom and when returned to storage and by whom; (v) The                                                          |
| where         | the date of such action, and by whom. where                                                                                                    |
| when          | When moved from storage and by whom and when returned to storage and by whom, including quantity                                               |
| when          | When moved from storage and by whom and when returned to storage and by whom, including quantity                                               |
| if            | the recipient are covered by the same cert if icate of registration), the toxin, the quantity transferred,                                     |
| where         | agent removal method was completed; (vi) The location where the validated inactivation or viable select agent removal                          |
| if            | Thefts or losses must be reported even  if the select agent or toxin is subsequently recovered                                                 |


## Entities

| Entities        | Context                                                                                                                                                 |
|:----------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------|
| Administrator   | Administrator .                                                                                                                                         |
| Animal          | Animal  and Plant Health Inspection Service (APHIS).                                                                                                    |
| Agriculture     | Health Inspection Service of the U.S. Department of Agriculture .                                                                                       |
| United States   | The Attorney General of the  United States or any person authorized to act for the                                                                      |
| Biological      | Biological  agent.                                                                                                                                      |
| Health          | Control and Prevention of the U.S. Department of Health  and Human Services.                                                                            |
| Diagnosis       | Diagnosis .                                                                                                                                             |
| Entity          | Entity .                                                                                                                                                |
| Health          | The Secretary of the Department of  Health and Human Services or his or her designee,                                                                   |
| Import          | Import .                                                                                                                                                |
| United States   | of movement into, the territorial limits of the United States .                                                                                         |
| Information     | Information  security.                                                                                                                                  |
| Columbia        | any other State, or within the District of Columbia , Guam, the Virgin Islands of the United                                                            |
| United States   | of Columbia, Guam, the Virgin Islands of the United States , or any other territory or possession of                                                    |
| United States   | of Columbia, Guam, the Virgin Islands of the United States , or any other territory or possession of                                                    |
| Overlap         | Overlap  select agent and/or toxin.                                                                                                                     |
| Permit          | Permit .                                                                                                                                                |
| Principal       | Principal  investigator.                                                                                                                                |
| Responsible     | Responsible  official.                                                                                                                                  |
| Security        | Security  barrier.                                                                                                                                      |
| Select          | Select  agent and/or toxin.                                                                                                                             |
| United States   | Any of the several States of the  United States , the Commonwealth of the Northern Mariana Islands,                                                     |
| Puerto Rico     | of the Northern Mariana Islands, the Commonwealth of Puerto Rico , the District of Columbia, Guam, the Virgin                                           |
| Columbia        | the Commonwealth of Puerto Rico, the District of Columbia , Guam, the Virgin Islands of the United                                                      |
| United States   | Any of the several States of the  United States , the Commonwealth of the Northern Mariana Islands,                                                     |
| United States   | Any of the several States of the  United States , the Commonwealth of the Northern Mariana Islands,                                                     |
| Synthetic       | Synthetic  nucleic acids.                                                                                                                               |
| Toxin           | Toxin .                                                                                                                                                 |
| United States   | United States .                                                                                                                                         |
| USDA            | USDA .                                                                                                                                                  |
| Agriculture     | The U.S. Department of  Agriculture .                                                                                                                   |
| Verification    | Verification .                                                                                                                                          |
| Purpose         | Purpose  and scope.                                                                                                                                     |
| Overlap         | Overlap select agents and toxins are subject to regulation                                                                                              |
| African         | (b) VS select agents and toxins:  African  horse sickness virus;                                                                                        |
| Avian           | African horse sickness virus; African swine fever virus; Avian influenza virus; Classical swine fever virus; *Foot-and-mouth disease                    |
| Mycoplasma      | virus; Goat pox virus; Lumpy skin disease virus; Mycoplasma  capricolum;                                                                                |
| Newcastle       | Lumpy skin disease virus; Mycoplasma capricolum; Mycoplasma mycoides; Newcastle disease virus;&#8201;1 Peste des petits ruminants virus; *Rinderpest    |
| Sheep           | virus;&#8201;1 Peste des petits ruminants virus; *Rinderpest virus; Sheep  pox virus; Swine vesicular disease virus.                                    |
| Swine           | petits ruminants virus; *Rinderpest virus; Sheep pox virus; Swine  vesicular disease virus.                                                             |
| Newcastle       | viruses which do not meet the criteria for Newcastle  disease virus,4                                                                                   |
|                 |                including those identified as pigeon paramyxovirus-12&#8201;5                                                                            |
| Overlap         | Overlap  select agents and toxins.                                                                                                                      |
| Brucella        | and toxins: *Bacillus anthracis; Bacillus anthracis (Pasteur strain); Brucella  abortus;                                                                |
| Brucella        | and toxins: *Bacillus anthracis; Bacillus anthracis (Pasteur strain); Brucella  abortus;                                                                |
| Brucella        | and toxins: *Bacillus anthracis; Bacillus anthracis (Pasteur strain); Brucella  abortus;                                                                |
| Nipah           | Brucella suis; *Burkholderia mallei; *Burkholderia pseudomallei; Hendra virus; Nipah virus; Rift Valley fever virus; Venezuelan equine encephalitis     |
| Venezuelan      | Hendra virus; Nipah virus; Rift Valley fever virus; Venezuelan  equine encephalitis virus.                                                              |
| Venezuelan      | (9) Any subtypes of  Venezuelan equine encephalitis virus except for Subtypes IAB or                                                                    |
| Burkholderia    | hours by telephone, facsimile, or e-mail: Bacillus anthracis, Burkholderia  mallei, or                                                                  |
| Burkholderia    | hours by telephone, facsimile, or e-mail: Bacillus anthracis, Burkholderia  mallei, or                                                                  |
| Fungicide       | (4) The Federal Insecticide,  Fungicide , and Rodenticide Act (7 U.S.C. 131 et                                                                          |
| Fungicide       | (4) The Federal Insecticide,  Fungicide , and Rodenticide Act (7 U.S.C. 131 et                                                                          |
| Health          | (f) Upon request of the Secretary of  Health and Human Services, the Administrator may exempt an                                                        |
| Health          | (f) Upon request of the Secretary of  Health and Human Services, the Administrator may exempt an                                                        |
| Denial          | Denial , revocation, or suspension of registration.                                                                                                     |
| Responsible     | Responsible  official.                                                                                                                                  |
| Bacillus        | swine fever virus, avian influenza virus (highly pathogenic), Bacillus anthracis, Burkholderia mallei, Burkholderia pseudomallei, classical swine fever |
| Burkholderia    | virus, avian influenza virus (highly pathogenic), Bacillus anthracis, Burkholderia  mallei,                                                             |
| Burkholderia    | virus, avian influenza virus (highly pathogenic), Bacillus anthracis, Burkholderia  mallei,                                                             |
| Security        | Security .                                                                                                                                              |
| Biosafety       | Biosafety .                                                                                                                                             |
| Microbiological | (1) The CDC/NIH publication, &#8220;Biosafety in  Microbiological and Biomedical Laboratories.&#8221; This document is available on                     |
| Training        | Training .                                                                                                                                              |
| United States   | select agent or toxin from outside of the United States  and meets all import requirements.                                                             |
| Information     | Information to be documented includes, but is not limited,                                                                                              |
| Federal         | or loss occurred; and (v) The list of Federal , State, or local law enforcement agencies to                                                             |


## Date

| Date       | Context                                                                                                       |
|:-----------|:--------------------------------------------------------------------------------------------------------------|
| 2018-01-01 | Response time must not exceed 5 minutes from the time of an intrusion alarm or report of a security incident; |
|            |             (iii) CCTV surveillance with 24/7 monitoring and recording; and                                   |
|            |             (iv) Transport vehicle with GPS tracking designed to serve as a containment vehicle.              |


